Andrew Webb
Vermogen: 944 329 $ op 30-06-2026
Vermogen: 944 329 $ op 30-06-2026
Mr. Andrew J.
Webb is an Executive Chairman & Chief Executive Officer at CRISM Therapeutics Corp.
and a Chief Executive Officer & Director at Extruded Pharmaceuticals Ltd. He is on the Board of Directors at Novel Technologies Holdings Ltd. and Extruded Pharmaceuticals Ltd. Mr. Webb was previously employed as a Commercial Director by DxS Ltd., a Non-Executive Director by Arcis Biotechnology Ltd., and a Chief Executive Officer by EKF Molecular Diagnostics Ltd. He also served on the board at Convert2Green Ltd.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
9,22% | 31-12-2025 | 7.297.190 ( 9,22% ) | 944 329 $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
Novel Technologies Holdings Ltd.
Novel Technologies Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Directeur/Bestuurslid | 23-11-2017 |
| Bedrijven | Functie | Einde |
|---|---|---|
DxS Ltd.
DxS Ltd. Medical SpecialtiesHealth Technology Develops and manufactures molecular diagnostics products | Corporate Officer/Principal | - |
EKF Molecular Diagnostics Ltd. | Algemeen Directeur | - |
Arcis Biotechnology Ltd.
Arcis Biotechnology Ltd. BiotechnologyHealth Technology Develops and researches surface protection technology | Directeur/Bestuurslid | - |
Convert2Green Ltd.
Convert2Green Ltd. Agricultural Commodities/MillingProcess Industries Provides renewable fuel solution | Directeur/Bestuurslid | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 5 |
|---|---|
DxS Ltd.
DxS Ltd. Medical SpecialtiesHealth Technology Develops and manufactures molecular diagnostics products | Health Technology |
Convert2Green Ltd.
Convert2Green Ltd. Agricultural Commodities/MillingProcess Industries Provides renewable fuel solution | Process Industries |
Arcis Biotechnology Ltd.
Arcis Biotechnology Ltd. BiotechnologyHealth Technology Develops and researches surface protection technology | Health Technology |
EKF Molecular Diagnostics Ltd. | |
Novel Technologies Holdings Ltd.
Novel Technologies Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Kies jouw editie
Alle financiële informatie op nationaal niveau